IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. scores highest on Nitro (72) and lowest on Earnings (20). Its PosiPenta is 44.36 out of 100, around the middle of similar companies.
On the Penta Grid this week, IDEAYA Biosciences, Inc. is Grid #399 of 837 in the Healthcare sector in United States, and Grid #2,479 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. | 44.36 | 24 | 20 | 72 | 67 | 40 |
| Acadia Pharmaceuticals Inc. | 57.44 | 66 | 49 | 47 | 76 | 49 |
| Liquidia Corporation | 53.66 | 31 | 73 | 39 | 59 | 67 |
| CareDx, Inc. | 58.13 | 30 | 50 | 91 | 77 | 44 |
| Amylyx Pharmaceuticals, Inc. | 42.31 | 5 | 39 | 69 | 53 | 46 |
| Tarsus Pharmaceuticals, Inc. | 49.45 | 7 | 53 | 70 | 54 | 62 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -16.93 |
| P/B ratio | 2.64 |
EEarnings
| Trailing EPS | ₹-183.75 |
| Forward EPS | ₹-394.32 |
NNitro
| Price | 3111.39 |
| 52-week high | 4042.43 |
| 52-week low | 2539.31 |
| Fall from 52-week high | 23.0% |
TTorque
| Return on equity (ROE) | -16.22% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | -0.04 |
| Market cap | ₹30,021 Cr |
| Insider holding | 2.19% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is IDEAYA Biosciences, Inc.'s PosiPenta score?
IDEAYA Biosciences, Inc.'s PosiPenta is 44.36 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does IDEAYA Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, IDEAYA Biosciences, Inc. is Grid #399 of 837 in the Healthcare sector in United States, and Grid #2,479 of 4,000 in United States.
Which PosiPenta pillar is strongest for IDEAYA Biosciences, Inc.?
Nitro (momentum), with a score of 72 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for IDEAYA Biosciences, Inc.?
Earnings (growth), with a score of 20 out of 100: much weaker than most similar companies.
Has IDEAYA Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.90 points, from 42.46 to 44.36.
PositoAI is for research and education only and is not investment advice.